Birchview Capital, LP Diversified Active

Location: Burlington, VT

CIK: 0001618205 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $214M (100.0% shares, 0.0% debt)

Holdings (73)

New Positions (15)

ABVX ABIVAX SA 1.1%
Value $2.265M Shares 17,000 Share Price $133.26 Est. Cost/Share — Unrealized @ Report Date —
VIR VIR BIOTECHNOLOGY INC 1.0%
Value $2.242M Shares 220,000 Share Price $10.19 Est. Cost/Share — Unrealized @ Report Date —
BIOA BIOAGE LABS INC 0.8%
Value $1.691M Shares 69,000 Share Price $24.51 Est. Cost/Share — Unrealized @ Report Date —
NVO NOVO NORDISK A/S 0.5%
Value $1.151M Shares 24,000 Share Price $47.94 Est. Cost/Share — Unrealized @ Report Date —
ADAG ADAGENE INC 0.5%
Value $1.008M Shares 240,000 Share Price $4.20 Est. Cost/Share — Unrealized @ Report Date —
DFTX DEFINIUM THERAPEUTICS INC 0.4%
Value $941K Shares 20,000 Share Price $47.04 Est. Cost/Share — Unrealized @ Report Date —
SLN SILENCE THERAPEUTICS PLC 0.4%
Value $782K Shares 71,218 Share Price $10.98 Est. Cost/Share — Unrealized @ Report Date —
FDMT 4D MOLECULAR THERAPEUTICS INC 0.3%
Value $645K Shares 48,505 Share Price $13.30 Est. Cost/Share — Unrealized @ Report Date —
URGN UROGEN PHARMA LTD 0.3%
Value $607K Shares 16,487 Share Price $36.80 Est. Cost/Share — Unrealized @ Report Date —
CAMP CAMP4 THERAPEUTICS CORP 0.2%
Value $524K Shares 120,000 Share Price $4.37 Est. Cost/Share — Unrealized @ Report Date —
SVRA SAVARA INC 0.2%
Value $493K Shares 80,000 Share Price $6.16 Est. Cost/Share — Unrealized @ Report Date —
ALT ALTIMMUNE INC 0.2%
Value $464K Shares 152,681 Share Price $3.04 Est. Cost/Share — Unrealized @ Report Date —
CAPR CAPRICOR THERAPEUTICS INC 0.2%
Value $346K Shares 14,352 Share Price $24.08 Est. Cost/Share — Unrealized @ Report Date —
IVVD INVIVYD INC 0.1%
Value $299K Shares 342,275 Share Price $0.87 Est. Cost/Share — Unrealized @ Report Date —
NTLA INTELLIA THERAPEUTICS INC (NTLA) C @ 13.0 10/16/2026 ⚠ 0.1%
Value $260K Shares 500 Share Price $520.00 Est. Cost/Share — Unrealized @ Report Date —

Increased Positions (11)

KLAC KLA CORPORATION 25.2%
Value $53.85M (+83.9%) Shares 178,471 (+797.6%) Share Price $301.71 Est. Cost/Share — Unrealized @ Report Date —
CMPX COMPASS THERAPEUTICS INC 1.7%
Value $3.668M (-52.7%) Shares 1,675,000 (+14.3%) Share Price $2.19 Est. Cost/Share — Unrealized @ Report Date —
NKTR NEKTAR THERAPEUTICS 2.6%
Value $5.655M (+153.5%) Shares 81,000 (+161.3%) Share Price $69.81 Est. Cost/Share — Unrealized @ Report Date —
CORT CORCEPT THERAPEUTICS INC 2.3%
Value $4.974M (+161.4%) Shares 57,200 (+21.2%) Share Price $86.95 Est. Cost/Share — Unrealized @ Report Date —
SLDB SOLID BIOSCIENCES INC 3.1%
Value $6.655M (+47.7%) Shares 666,196 (+6.4%) Share Price $9.99 Est. Cost/Share — Unrealized @ Report Date —
HALO HALOZYME THERAPEUTICS INC 1.2%
Value $2.603M (+298.7%) Shares 33,251 (+229.2%) Share Price $78.27 Est. Cost/Share — Unrealized @ Report Date —
BIIB BIOGEN INC 0.9%
Value $1.945M (+112.1%) Shares 9,000 (+80.0%) Share Price $216.06 Est. Cost/Share — Unrealized @ Report Date —
ZBIO ZENAS BIOPHARMA INC 1.1%
Value $2.376M (+73.6%) Shares 93,601 (+33.7%) Share Price $25.38 Est. Cost/Share — Unrealized @ Report Date —
VERA VERA THERAPEUTICS INC 1.2%
Value $2.478M (+40.0%) Shares 57,758 (+31.3%) Share Price $42.91 Est. Cost/Share — Unrealized @ Report Date —
— QUIDELORTHO CORP 0.7%
Value $1.565M (+15.4%) Shares 89,377 (+8.3%) Share Price $17.51 Est. Cost/Share — Unrealized @ Report Date —
GRCE GRACE THERAPEUTICS INC 0.1%
Value $272K (+17.7%) Shares 120,000 (+140.0%) Share Price $2.27 Est. Cost/Share — Unrealized @ Report Date —

Exited Positions (15)

NVCR NOVOCURE LTD 1.0%
Value $2.205M Shares 202,330 Share Price $10.90 Est. Cost/Share — Unrealized @ Report Date —
ENGN ENGENE HOLDINGS INC 0.8%
Value $1.702M Shares 250,000 Share Price $6.81 Est. Cost/Share — Unrealized @ Report Date —
RARE ULTRAGENYX PHARMACEUTICAL INC 0.6%
Value $1.299M Shares 62,000 Share Price $20.95 Est. Cost/Share — Unrealized @ Report Date —
KALV KALVISTA PHARMACEUTICALS INC 0.5%
Value $1.147M Shares 57,000 Share Price $20.13 Est. Cost/Share — Unrealized @ Report Date —
VSTM VERASTEM INC 0.4%
Value $795K Shares 150,000 Share Price $5.30 Est. Cost/Share — Unrealized @ Report Date —
APGE APOGEE THERAPEUTICS INC 0.4%
Value $758K Shares 9,000 Share Price $84.17 Est. Cost/Share — Unrealized @ Report Date —
APLS APELLIS PHARMACEUTICALS INC 0.3%
Value $563K Shares 14,000 Share Price $40.23 Est. Cost/Share — Unrealized @ Report Date —
IDYA IDEAYA BIOSCIENCES INC 0.3%
Value $562K Shares 16,860 Share Price $33.32 Est. Cost/Share — Unrealized @ Report Date —
RCUS ARCUS BIOSCIENCES INC 0.3%
Value $559K Shares 25,889 Share Price $21.60 Est. Cost/Share — Unrealized @ Report Date —
RGNX REGENXBIO INC 0.3%
Value $555K Shares 66,270 Share Price $8.38 Est. Cost/Share — Unrealized @ Report Date —
RCKT ROCKET PHARMACEUTICALS INC 0.2%
Value $455K Shares 127,025 Share Price $3.58 Est. Cost/Share — Unrealized @ Report Date —
VRDN VIRIDIAN THERAPEUTICS INC 0.2%
Value $393K Shares 20,100 Share Price $19.56 Est. Cost/Share — Unrealized @ Report Date —
— OUTSET MEDICAL INC 0.2%
Value $380K Shares 98,882 Share Price $3.84 Est. Cost/Share — Unrealized @ Report Date —
PHR PHREESIA INC 0.1%
Value $120K Shares 14,300 Share Price $8.38 Est. Cost/Share — Unrealized @ Report Date —
ZNTL ZENTALIS PHARMACEUTICALS INC 0.0%
Value $40,957 Shares 17,503 Share Price $2.34 Est. Cost/Share — Unrealized @ Report Date —

Decreased Positions (17)

LRCX LAM RESEARCH CORPORATION 7.1%
Value $15.17M (+97.2%) Shares 35,000 (-2.8%) Share Price $433.33 Est. Cost/Share — Unrealized @ Report Date —
GPCR STRUCTURE THERAPEUTICS INC 0.6%
Value $1.288M (-73.3%) Shares 24,000 (-76.0%) Share Price $53.67 Est. Cost/Share — Unrealized @ Report Date —
OCUL OCULAR THERAPEUTIX INC 0.1%
Value $203K (-92.5%) Shares 20,655 (-93.5%) Share Price $9.82 Est. Cost/Share — Unrealized @ Report Date —
CMPS COMPASS PATHWAYS LTD 0.2%
Value $425K (-79.5%) Shares 30,000 (-92.0%) Share Price $14.15 Est. Cost/Share — Unrealized @ Report Date —
PHAT PHATHOM PHARMACEUTICALS INC 0.3%
Value $597K (-72.5%) Shares 55,000 (-71.8%) Share Price $10.85 Est. Cost/Share — Unrealized @ Report Date —
BMY BRISTOL-MYERS SQUIBB CO 8.0%
Value $17.13M (-7.8%) Shares 297,243 (-2.9%) Share Price $57.62 Est. Cost/Share — Unrealized @ Report Date —
STOK STOKE THERAPEUTICS INC 2.7%
Value $5.828M (-14.8%) Shares 178,110 (-15.2%) Share Price $32.72 Est. Cost/Share — Unrealized @ Report Date —
LPCN LIPOCINE INC 0.0%
Value $42,783 (-95.2%) Shares 16,712 (-85.1%) Share Price $2.56 Est. Cost/Share — Unrealized @ Report Date —
BCYC BICYCLE THERAPEUTICS PLC 0.6%
Value $1.33M (-38.2%) Shares 313,616 (-32.4%) Share Price $4.24 Est. Cost/Share — Unrealized @ Report Date —
NTLA INTELLIA THERAPEUTICS INC ⚠ 3.0%
Value $6.521M (+14.2%) Shares 385,400 (-13.5%) Share Price $16.92 Est. Cost/Share — Unrealized @ Report Date —
OLMA OLEMA PHARMACEUTICALS INC 1.2%
Value $2.489M (-23.8%) Shares 199,000 (-9.1%) Share Price $12.51 Est. Cost/Share — Unrealized @ Report Date —
QURE UNIQURE NV 1.1%
Value $2.335M (+41.8%) Shares 50,697 (-49.7%) Share Price $46.06 Est. Cost/Share — Unrealized @ Report Date —
PACB PACIFIC BIOSCIENCES OF CALIFORNIA INC 1.1%
Value $2.268M (+14.5%) Shares 1,350,000 (-10.0%) Share Price $1.68 Est. Cost/Share — Unrealized @ Report Date —
CADL CANDEL THERAPEUTICS INC 0.2%
Value $492K (+67.3%) Shares 47,756 (-20.4%) Share Price $10.30 Est. Cost/Share — Unrealized @ Report Date —
LUNG PULMONX CORP 0.1%
Value $261K (-19.2%) Shares 200,543 (-19.9%) Share Price $1.30 Est. Cost/Share — Unrealized @ Report Date —
— KARYOPHARM THERAPEUTICS INC 0.2%
Value $420K (-10.3%) Shares 42,952 (-48.8%) Share Price $9.77 Est. Cost/Share — Unrealized @ Report Date —
DCGO DOCGO INC 0.0%
Value $20,160 (-19.0%) Shares 39,062 (-1.3%) Share Price $0.52 Est. Cost/Share — Unrealized @ Report Date —

Unchanged Positions (30)

— BIODESIX INC 3.0%
Value $6.467M Shares 286,804 Share Price $22.55 Est. Cost/Share — Unrealized @ Report Date —
NBIX NEUROCRINE BIOSCIENCES INC 2.1%
Value $4.582M Shares 27,190 Share Price $168.54 Est. Cost/Share — Unrealized @ Report Date —
ALKS ALKERMES PLC 1.2%
Value $2.62M Shares 50,000 Share Price $52.40 Est. Cost/Share — Unrealized @ Report Date —
TVTX TRAVERE THERAPEUTICS INC 0.8%
Value $1.647M Shares 29,000 Share Price $56.81 Est. Cost/Share — Unrealized @ Report Date —
OVV OVINTIV INC 2.6%
Value $5.66M Shares 107,500 Share Price $52.65 Est. Cost/Share — Unrealized @ Report Date —
PTGX PROTAGONIST THERAPEUTICS INC 2.0%
Value $4.293M Shares 35,018 Share Price $122.58 Est. Cost/Share — Unrealized @ Report Date —
CYTK CYTOKINETICS INC 1.2%
Value $2.556M Shares 30,000 Share Price $85.19 Est. Cost/Share — Unrealized @ Report Date —
ACAD ACADIA PHARMACEUTICALS INC 2.0%
Value $4.326M Shares 171,000 Share Price $25.30 Est. Cost/Share — Unrealized @ Report Date —
AXSM AXSOME THERAPEUTICS INC 0.7%
Value $1.469M Shares 6,000 Share Price $244.77 Est. Cost/Share — Unrealized @ Report Date —
CLDX CELLDEX THERAPEUTICS INC 1.2%
Value $2.601M Shares 69,900 Share Price $37.21 Est. Cost/Share — Unrealized @ Report Date —
EQT EQT CORPORATION 0.9%
Value $1.841M Shares 34,619 Share Price $53.17 Est. Cost/Share — Unrealized @ Report Date —
UTHR UNITED THERAPEUTICS CORP 1.1%
Value $2.441M Shares 4,506 Share Price $541.83 Est. Cost/Share — Unrealized @ Report Date —
PHVS PHARVARIS N V 0.5%
Value $1.032M Shares 29,847 Share Price $34.58 Est. Cost/Share — Unrealized @ Report Date —
HROW HARROW HEALTH INC 0.5%
Value $1.019M Shares 24,000 Share Price $42.47 Est. Cost/Share — Unrealized @ Report Date —
CGEM CULLINAN THERAPEUTICS INC 0.2%
Value $364K Shares 20,000 Share Price $18.21 Est. Cost/Share — Unrealized @ Report Date —
FCX FREEPORT-MCMORAN CL-B 0.5%
Value $1.134M Shares 18,035 Share Price $62.89 Est. Cost/Share — Unrealized @ Report Date —
TRIN TRINITY CAP INC 0.2%
Value $358K Shares 20,000 Share Price $17.89 Est. Cost/Share — Unrealized @ Report Date —
XENE XENON PHARMACEUTICALS INC 0.6%
Value $1.269M Shares 21,032 Share Price $60.36 Est. Cost/Share — Unrealized @ Report Date —
QNRX QUOIN PHARMACEUTICALS LTD 0.0%
Value $96,800 Shares 20,000 Share Price $4.84 Est. Cost/Share — Unrealized @ Report Date —
IMNM IMMUNOME INC 0.5%
Value $1.06M Shares 50,000 Share Price $21.19 Est. Cost/Share — Unrealized @ Report Date —
PRTA PROTHENA CORP PLC 2.1%
Value $4.396M Shares 449,019 Share Price $9.79 Est. Cost/Share — Unrealized @ Report Date —
FHTX FOGHORN THERAPEUTICS INC 0.6%
Value $1.376M Shares 281,937 Share Price $4.88 Est. Cost/Share — Unrealized @ Report Date —
VYGR VOYAGER THERAPEUTICS INC 0.1%
Value $263K Shares 75,147 Share Price $3.50 Est. Cost/Share — Unrealized @ Report Date —
RLMD RELMADA THERAPEUTICS INC 1.3%
Value $2.824M Shares 408,100 Share Price $6.92 Est. Cost/Share — Unrealized @ Report Date —
KYNB KYNTRA BIO INC 0.1%
Value $170K Shares 22,566 Share Price $7.55 Est. Cost/Share — Unrealized @ Report Date —
ELUT ELUTIA INC 0.1%
Value $162K Shares 165,094 Share Price $0.98 Est. Cost/Share — Unrealized @ Report Date —
CSTL CASTLE BIOSCIENCES INC 0.1%
Value $310K Shares 12,984 Share Price $23.85 Est. Cost/Share — Unrealized @ Report Date —
BBIO BRIDGEBIO PHARMA INC 0.3%
Value $651K Shares 8,741 Share Price $74.48 Est. Cost/Share — Unrealized @ Report Date —
KBDC KAYNE ANDERSON BDC INC 0.1%
Value $271K Shares 20,000 Share Price $13.53 Est. Cost/Share — Unrealized @ Report Date —
GOSS GOSSAMER BIO INC 0.0%
Value $2,992 Shares 18,176 Share Price $0.16 Est. Cost/Share — Unrealized @ Report Date —